Nahrin AG

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED2 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Nahrin AG

Is Nahrin AG on an FDA import alert?

Yes. As of October 25, 2026, Nahrin AG is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for age-defy immunity and regeneressence food supplement; energy focus & performance food supplement; FDA published the listing on July 7, 2023.

Has FDA refused shipments from Nahrin AG?

Yes. FDA refused 2 shipment lines from Nahrin AG on June 16, 2023. The most recent, on June 16, 2023, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Nahrin AG's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 2 lines).

What is Nahrin AG's FEI number?

Nahrin AG's FDA Establishment Identifier (FEI) is 3017652491.

Can shipments from Nahrin AG still enter the U.S.?

Shipments of age-defy immunity and regeneressence food supplement; energy focus & performance food supplement from Nahrin AG can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).